| A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors (NCT05194072) | Seagen, a wholly owned subsidiary of Pfizer | 2022-01-12 |
| Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial (NCT04883671) | Dana-Farber Cancer Institute | 2021-12-27 |
| AL101 Before Surgery for the Treatment of Notch Activated Adenoid Cystic Cancer (NCT04973683) | M.D. Anderson Cancer Center | 2021-09-30 |
| 9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma (NCT05010629) | Glenn J. Hanna | 2021-09-17 |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC (NCT04140526) | OncoC4, Inc. | 2020-09-16 |
| Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617 (NCT04801264) | Peking Union Medical College Hospital | 2020-09-01 |
| Lenvatinib and Pembrolizumab in People With Advanced Adenoid Cystic Carcinoma and Other Salivary Gland Cancers (NCT04209660) | Memorial Sloan Kettering Cancer Center | 2020-06-02 |
| Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients (NCT04291300) | Radboud University Medical Center | 2020-05-26 |
| P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC) (NCT04249947) | Poseida Therapeutics, Inc. | 2020-02-28 |
| A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC) (NCT04119453) | Elevar Therapeutics | 2020-01-22 |
| Adenoid Cystic Carcinoma and Carbon Ion Only Irradiation (NCT04214366) | Heidelberg University | 2019-12-01 |
| A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies (NCT03886831) | Prelude Therapeutics | 2019-02-11 |
| A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations (NCT03691207) | Ayala Pharmaceuticals, Inc, | 2018-12-14 |
| MYPHISMO: MYB and PD-1 Immunotherapies Against Multiple Oncologies Trial (NCT03287427) | Peter MacCallum Cancer Centre, Australia | 2018-08-22 |
| VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma (NCT03556228) | VM Oncology, LLC | 2018-06-08 |
| Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies (NCT03422679) | Cellestia Biotech AG | 2017-12-05 |
| PSMA-PET Imaging for Advanced ACC/SDC (NCT03319641) | Radboud University Medical Center | 2017-10-25 |
| Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma (NCT03087019) | Dana-Farber Cancer Institute | 2017-04-25 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Trail Evaluating Particle Therapy With or Without Apatinib for H&N Adenoid Cystic Carcinoma (NCT02942693) | Shanghai Proton and Heavy Ion Center | 2016-11-01 |
| Testing Lenvatinib in Patients With Adenoid Cystic Carcinoma (NCT02780310) | Memorial Sloan Kettering Cancer Center | 2016-05-19 |
| Surgical Strategy for Head and Neck Adenoid Cystic Cancer (NCT06778915) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2016-01-01 |
| Compassionate Use of Brontictuzumab for Adenoid Cystic Carcinoma (ACC) (NCT02662608) | M.D. Anderson Cancer Center | 2015-12-29 |
| Regorafenib in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma (NCT02098538) | Memorial Sloan Kettering Cancer Center | 2014-03-01 |
| Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy (NCT01192087) | Heidelberg University | 2012-06-01 |
| Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma (NCT01524692) | University of Virginia | 2012-03-01 |
| Axitinib (AG-013736) in Patients With Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma (NCT01558661) | Memorial Sloan Kettering Cancer Center | 2012-03-01 |
| Dovitinib in Adenoid Cystic Carcinoma (NCT01417143) | Seoul National University Hospital | 2011-09-01 |
| Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy (NCT01586767) | Massachusetts General Hospital | 2011-07-12 |
| Study of RAD001 in Adenoid Cystic Carcinoma (NCT01152840) | Seoul National University Hospital | 2008-07-01 |
| Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck (NCT00581360) | University of Pittsburgh | 2007-11-01 |
| A Study of Sunitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands (NCT00886132) | University Health Network, Toronto | 2007-01-01 |